BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2018
View Archived Issues
Axsome reports topline phase I results on AXS-09
Read More
Valeant enters licensing agreement with Kaken for KP-470-based products for psoriasis
Read More
BioAtla treats first patient in phase I/II study of antibody-drug conjugate targeting AXL
Read More
DRP1 inhibitor mdivi-1 improves outcomes after experimental cardiac arrest
Read More
Novel microRNAs found largely overexpressed in children with severe sepsis
Read More
MabVax reports interim results from first cohort of phase I MVT-1075 study
Read More
Novavax reports topline results from phase I/II trial of NanoFlu in older adults
Read More
EMA grants orphan drug designation to MTD-119 for hepatocellular carcinoma
Read More
Synthetic Genomics' bacteriophage platform to be integrated with C3J's R&D programs
Read More
FDA approves ZTlido lidocaine topical system
Read More
Viela Bio spins out of MedImmune
Read More
Stimunity to receive investment from Portage Biotech
Read More
Endocyte launching phase III registration study of [177Lu]PSMA-617
Read More
Low NAA levels correlate with better outcomes in patients with severe TBI
Read More
MSD applies for approval of tazobactam sodium/ceftolozane sulfate combination in Japan
Read More
Asterias updates data from phase I/IIa SCiStar study of AST-OPC1 for severe spinal cord injury
Read More
Mylan and Revance sign global collaboration and license agreement for Botox biosimilar
Read More
Novel mTORC1/2 inhibitor DCZ-0358 overcomes bone marrow microenvironment to combat multiple myeloma
Read More
Sutro initiates phase I study of STRO-001 in advanced B-cell malignancies
Read More
Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis
Read More
Stragen initiates phase I Paincart trial of STR-324
Read More
FronThera US Pharmaceuticals divulges new HIF2-alpha inhibitors
Read More
Novartis and Pear to collaborate on prescription software applications for schizophrenia and MS
Read More
Dompe Farmaceutici identifies novel FFAR1 agonists
Read More
Pharmascience discloses Tec family kinase inhibitors
Read More
Sunshine Lake Pharma presents influenza A H1N1 inhibitors
Read More
Jiangsu patents novel FGFR-4 inhibitors
Read More